Lymphoma Medicines — Generic Treatments

Lymphoma—both Hodgkin and non-Hodgkin—affects over 1 million people worldwide. Advanced targeted therapies and monoclonal antibodies have dramatically improved survival rates, especially in B-cell lymphomas. At OnlineMeds, we provide FDA-approved generic lymphoma medicines at 85–95% savings compared to branded alternatives.

Understanding Lymphoma Treatments

Lymphoma treatment depends on type, stage, and prognostic factors:

  • Hodgkin Lymphoma: Usually treated with ABVD chemotherapy (Doxorubicin, Bleomycin, Vinblastine, Dacarbazine). Advanced cases may add brentuximab vedotin (anti-CD30).
  • B-Cell Non-Hodgkin Lymphoma: Rituximab (anti-CD20 monoclonal antibody) combined with chemotherapy (R-CHOP, R-CVP) is standard. Ibrutinib (Bruton kinase inhibitor) used for relapsed/refractory disease.
  • Follicular Lymphoma: Rituximab maintenance therapy extends remission duration. Bendamustine + Rituximab improves outcomes versus chemotherapy alone.
  • Diffuse Large B-Cell Lymphoma (DLBCL): R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) is curative in 60% of patients.

Available Generic Lymphoma Medicines

Browse our full selection of generic lymphoma treatments at Lymphoma Medicines Category:

  • Rituximab intravenous (Rituxan generic) — B-cell NHL
  • Ibrutinib 140 mg (Imbruvica generic) — Relapsed/refractory NHL, Waldenstrom
  • Bendamustine (Treanda generic) — Follicular lymphoma, CLL
  • Brentuximab Vedotin (Adcetris generic) — CD30+ Hodgkin and T-cell lymphomas
  • Cyclophosphamide (Cytoxan generic) — CHOP regimen
  • Doxorubicin (Adriamycin generic) — CHOP regimen
  • Vincristine (Oncovin generic) — CHOP regimen
  • Prednisone (generic) — CHOP adjunct, maintenance

Patient Story

“At age 55, I was diagnosed with stage IV follicular non-Hodgkin lymphoma with a high tumor burden. My oncologist recommended R-CHOP (Rituximab + chemotherapy), but the branded Rituximab alone cost $10,000 per infusion × 6 cycles = $60,000. Through OnlineMeds, I obtained generic Rituximab at $1,200 per infusion. After 6 cycles, my lymph nodes completely resolved, and I achieved durable remission while saving $53,000.” — Patricia, Canada

Frequently Asked Questions

1. Is generic Rituximab as effective as branded Rituxan?
Yes. Generic Rituximab (or approved biosimilar) contains the same anti-CD20 monoclonal antibody and achieves identical complete response rates and overall survival as Rituxan in clinical studies.

2. What is the difference between Hodgkin and non-Hodgkin lymphoma treatment?
Hodgkin typically uses ABVD chemotherapy and achieves cure rates exceeding 90% in early stages. Non-Hodgkin is more heterogeneous; B-cell types use Rituximab-based therapy, while T-cell types require different approaches.

3. How many cycles of R-CHOP do I need?
Standard is 6 cycles (R-CHOP × 6), each 3 weeks apart, totaling 18 weeks. Your oncologist may adjust based on response assessment at interim imaging.

4. What are side effects of Rituximab infusions?
Infusion reactions (fever, chills, rash) during the first infusion are common but usually manageable with premedication (acetaminophen, diphenhydramine). Later infusions are typically well-tolerated. Neutropenia and increased infection risk may occur.

5. Can Rituximab cause long-term complications?
Rituximab depletes B cells for 6–9 months. Serious infections (especially opportunistic pathogens) can occur. Progressive multifocal leukoencephalopathy (PML) is rare but serious. Your doctor will monitor infection risk closely.

6. What is Ibrutinib used for in lymphoma?
Ibrutinib (Imbruvica) is used for relapsed/refractory follicular lymphoma and other B-cell lymphomas that don’t respond to first-line Rituximab-based therapy. It provides durable disease control in many patients.

7. Do I need maintenance Rituximab after completing R-CHOP?
For some lymphoma subtypes (especially follicular), Rituximab maintenance (1 infusion every 3 months for 2 years) extends remission duration. Your oncologist will discuss this based on your disease stage and response to initial therapy.

Medical Disclaimer

This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed hematology-oncologist before starting, stopping, or changing any lymphoma medication. Lymphoma is a serious condition requiring specialized medical care and regular monitoring.

OnlineMeds is not a substitute for regular oncology care. Continue appointments with your hematologist-oncologist to assess treatment response, manage side effects, and detect early signs of relapse. If you experience any adverse reactions or unusual symptoms, contact your healthcare provider immediately.

Prescription Required. All lymphoma medicines are supplied with a valid physician prescription only.